<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01300754</url>
  </required_header>
  <id_info>
    <org_study_id>UNRosario</org_study_id>
    <nct_id>NCT01300754</nct_id>
  </id_info>
  <brief_title>Effectiveness of Dextrose Injection for Osgood-Schlatter Disease</brief_title>
  <official_title>Phase 2 Study of Dextrose Injection for Sport-Limiting Osgood Schlatter Disease in Adolescents.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Nacional de Rosario</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Nacional de Rosario</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To examine the potential of dextrose injection versus lidocaine injection versus
      supervised usual care to change pain/function/activity levels in adolescent athletes with
      Osgood-Schlatter Disease (OSD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients and methods: Girls ages 9-15 years old and boys ages 10-17 years old will be
      assigned to either therapist-supervised usual care, or to double-blind injection of 1%
      lidocaine solution with or without 12.5% dextrose. Injections will be administered monthly
      for three months. All subjects will then be offered dextrose injections monthly as needed.
      Change in the Nirschl Pain Phase Scale (NPPS) will serve as the primary outcome measure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Osgood-Schlatter Disease</condition>
  <arm_group>
    <arm_group_label>Dextrose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dextrose Injection</intervention_name>
    <description>12.5 Dextrose in 1% Lidocaine injected monthly for 3 months with a 27 gauge needle on painful areas of the tibial tuberosity, under the patellar tendon.</description>
    <arm_group_label>Dextrose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lidocaine Injection</intervention_name>
    <description>1% Lidocaine injected monthly for 3 months with a 27 gauge needle on painful areas of the tibial tuberosity, under the patellar tendon.</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Therapist supervised exercises that are standard of care for Osgood-Schatter Disease as well as relative rest and gradual resumption of pain-limited sport.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age:9-15 year old girls and 10-17 year old boys

          -  Pain Location: Anterior knee.

          -  Sport Type: Jumping or kicking sport.

          -  Team Member with Coach: Member of and organized team with a coach.

          -  Imitation of exact pain and precise location to the tibial tuberosity with a single
             leg squat.

          -  At least 2 months of formal and gently progressive hamstring stretching, quads
             strengthening, and gradual sports reintroduction.

          -  Pain with sport at least 3 months.

        Exclusion Criteria:

          -  Patellofemoral crepitus

          -  Patellar origin tenderness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaston A Topol, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Provincial de Rosario</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Provincial de Rosario</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2011</study_first_submitted>
  <study_first_submitted_qc>February 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2011</study_first_posted>
  <last_update_submitted>February 22, 2011</last_update_submitted>
  <last_update_submitted_qc>February 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Gastón Andrés Topol, M.D.</name_title>
    <organization>Hospital Provincial de Rosario</organization>
  </responsible_party>
  <keyword>Osgood-Schlatter</keyword>
  <keyword>Tendinosis</keyword>
  <keyword>Apophysitis</keyword>
  <keyword>Enthesopathy</keyword>
  <keyword>Dextrose.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteochondrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

